Twenty years ago, eGenesis CEO Paul Sekhri watched as his colleagues at Novartis tried and ultimately failed…
sciencecityNovember 12, 2019
-Sigilon Therapeutics announced today that it will present data at the American Society of Hematology Annual…
sciencecityNovember 8, 2019
Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard…
sciencecityNovember 8, 2019
A new study from the laboratory of Frederick Alt, PhD, of the Program in Cellular and Molecular Medicine (PCMM) at…
sciencecityNovember 7, 2019
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling…
sciencecityNovember 7, 2019
As people age, they tend to develop diseases such as heart failure, kidney failure, diabetes,…
sciencecityNovember 6, 2019
Researchers from MIT will be collaborating with colleagues at the University of Colorado at Boulder…
sciencecityNovember 6, 2019
Blood clotting in veins, a disorder called venous thromboembolism (VTE), is a common vascular disease…
sciencecityNovember 6, 2019
A variety of factors can stop hair from forming and growing properly, leading to hair…
sciencecityNovember 5, 2019
